OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophage internalization creates a multidrug-tolerant fungal persister reservoir and facilitates the emergence of drug resistance
Amir Arastehfar, Farnaz Daneshnia, Nathaly Cabrera, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 31

Reactive oxidant species induced by antifungal drugs: identity, origins, functions, and connection to stress-induced cell death
Irene González-Jiménez, David S. Perlin, Erika Shor
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 26

Confronting antifungal resistance, tolerance, and persistence: Advances in drug target discovery and delivery systems
Lei Chen, Lanyue Zhang, Yuyan Xie, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 115007-115007
Closed Access | Times Cited: 25

Fungicide-tolerant persister formation during cryptococcal pulmonary infection
Weixin Ke, Yuyan Xie, Yingying Chen, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 276-289.e7
Open Access | Times Cited: 14

Antibacterial Plasma Coating with Aggregation‐Induced Emission Photosensitizers to Prevent Surgical Site Infections
R. B. Sahu, Neethu Ninan, Ngoc Huu Nguyen, et al.
Advanced Materials Interfaces (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 6

Immunometabolic Regulation of Bacterial Infection, Biofilms, and Antibiotic Susceptibility
Y. Chen, Gaurav Kumar Lohia, Samantha Chen, et al.
Journal of Innate Immunity (2024) Vol. 16, Iss. 1, pp. 143-158
Open Access | Times Cited: 6

Mechanisms of multidrug resistance caused by an Ipi1 mutation in the fungal pathogen Candida glabrata
Taiga Miyazaki, Shintaro Shimamura, Yohsuke Nagayoshi, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Heterogeneity ofCandidabloodstream isolates in an academic medical center and affiliated hospitals
Nancy E. Scott, Elizabeth Wash, Christopher Zajac, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance
Yanyu Su, Yi Li, Qiaolian Yi, et al.
Journal of Fungi (2025) Vol. 11, Iss. 2, pp. 143-143
Open Access

How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of View
Angioletta Lasagna, Patrizia Cambieri, Fausto Baldanti, et al.
JCO Oncology Practice (2025)
Closed Access

Evolution of Small Molecule Inhibitors of Mycobacterium tuberculosis Menaquinone Biosynthesis
Pankaj Sharma, Quan Jiang, Shaogang Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness
Amir Arastehfar, Farnaz Daneshnia, Hrant Hovhannisyan, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 11

Candida parapsilosis isolates carrying mutations outside FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance
Farnaz Daneshnia, Amir Arastehfar, Lisa Lombardi, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 1, pp. 106831-106831
Open Access | Times Cited: 10

Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis
Yasmine Hassoun, Ariel A. Aptekmann, Mikhail V. Keniya, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012521-e1012521
Open Access | Times Cited: 2

Persistence and Culturability of Escherichia coli under Induced Toxin Expression
Yousr Dhaouadi, Mohamad Javad Hashemi, Dacheng Ren
Antibiotics (2024) Vol. 13, Iss. 9, pp. 863-863
Open Access | Times Cited: 1

Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi
Stef Jacobs, Giorgio Boccarella, Pieter van den Berg, et al.
npj Antimicrobials and Resistance (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1

“We've got to get out”—Strategies of human pathogenic fungi to escape from phagocytes
Johannes Sonnberger, Lydia Kasper, Theresa Lange, et al.
Molecular Microbiology (2023) Vol. 121, Iss. 3, pp. 341-358
Open Access | Times Cited: 4

Effects of resveratrol on macrophages after phagocytosis of Candida glabrata
Zong-Han Chen, Meng Guan, Weijia Zhao
International Journal of Medical Microbiology (2023) Vol. 313, Iss. 6, pp. 151589-151589
Open Access | Times Cited: 4

OverlookedCandida glabratapetites are echinocandin tolerant, induce host inflammatory responses, and display poorin vivofitness
Amir Arastehfar, Farnaz Daneshnia, Hrant Hovhannisyan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Unlocking the enigma of phenotypic drug tolerance: Mechanisms and emerging therapeutic strategies
Alok Mishra, Ritesh P. Thakare, Bela G. Santani, et al.
Biochimie (2023) Vol. 220, pp. 67-83
Closed Access | Times Cited: 3

Exploring emerging drug responses in Cryptococcus
Wei Liu, Yiru Gao, Chen Ding
Trends in Microbiology (2024) Vol. 32, Iss. 10, pp. 940-943
Closed Access

Implication of genotypes for prognosis of Candida glabrata bloodstream infections
Pao-Yu Chen, Yu‐Shan Huang, Yu‐Chung Chuang, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 8, pp. 2008-2016
Open Access

Therapeutic Potential of Phytochemicals and Their Derivatives as Antifungal Candidates: Recent Discovery and Development
Kashish Azeem, Iram Irfan, Mohd. Shakir, et al.
(2024), pp. 517-534
Closed Access

A multidimensional assessment of in-host fitness costs of drug resistance in the opportunistic fungal pathogen Candida glabrata
Amir Arastehfar, Farnaz Daneshnia, Hrant Hovhannisyan, et al.
FEMS Yeast Research (2024) Vol. 24
Open Access

Page 1 - Next Page

Scroll to top